Kuros Biosciences AG (CSBTF)

USD 22.57

(0.0%)

Long Term Debt Summary of Kuros Biosciences AG

  • Kuros Biosciences AG's latest annual long term debt in 2023 was 1.56 Million CHF , up 4.54% from previous year.
  • Kuros Biosciences AG's latest quarterly long term debt in 2024 Q2 was 3.6 Million CHF , down 0.0% from previous quarter.
  • Kuros Biosciences AG reported annual long term debt of 1.49 Million CHF in 2022, down -18.15% from previous year.
  • Kuros Biosciences AG reported annual long term debt of 1.82 Million CHF in 2021, down -11.3% from previous year.
  • Kuros Biosciences AG reported quarterly long term debt of - CHF for 2024 Q1, down 0.0% from previous quarter.
  • Kuros Biosciences AG reported quarterly long term debt of 2.28 Million CHF for 2023 Q1, up 52.91% from previous quarter.

Annual Long Term Debt Chart of Kuros Biosciences AG (2023 - 2004)

Historical Annual Long Term Debt of Kuros Biosciences AG (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 1.56 Million CHF 4.54%
2022 1.49 Million CHF -18.15%
2021 1.82 Million CHF -11.3%
2020 2.06 Million CHF -3.73%
2019 2.14 Million CHF 0.0%
2018 - CHF 0.0%
2017 - CHF 0.0%
2016 - CHF 0.0%
2015 - CHF 0.0%
2014 - CHF -100.0%
2013 25.16 Million CHF 80.83%
2012 13.91 Million CHF 0.0%
2011 - CHF -100.0%
2010 39.03 Million CHF -24.73%
2009 51.86 Million CHF -14.82%
2008 60.88 Million CHF 4.26%
2007 58.4 Million CHF 5267.74%
2006 1.08 Million CHF 0.0%
2005 - CHF 0.0%
2004 - CHF 0.0%

Peer Long Term Debt Comparison of Kuros Biosciences AG

Name Long Term Debt Long Term Debt Difference
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 92.515%
Evofem Biosciences, Inc. 8000.00 USD -19462.5%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 10.851%
Mesoblast Limited 100.29 Million USD 98.44%
Propanc Biopharma, Inc. 58.64 Thousand USD -2568.736%
Genus plc 228.2 Million USD 99.314%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD -134.587%
ContraFect Corporation 2.21 Million USD 29.186%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -11.552%
Intellipharmaceutics International Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 71.16%
MultiCell Technologies, Inc. 36.43 USD -4295809.964%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 97.186%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 29.695%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -27.406%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.058%
Oncotelic Therapeutics, Inc. 1.89 Million USD 17.565%
Skye Bioscience, Inc. 171.23 Thousand USD -813.975%
Therapeutic Solutions International, Inc. 5512.00 USD -28292.598%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 94.288%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -386.025%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.986%
Halberd Corporation 150 Thousand USD -943.333%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD -421.667%
Nuo Therapeutics, Inc. 164.2 Thousand USD -853.077%
argenx SE 15.35 Million USD 89.807%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 92.295%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -35021.185%
Genscript Biotech Corporation 287.12 Million USD 99.455%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -1139.094%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -582.539%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -182.19%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -6086.015%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 81.062%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -489.154%
ONE Bio Corp. 592.19 Thousand USD -164.27%
Reve Technologies, Inc. 1064.00 USD -146986.466%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -946.025%
Regen BioPharma, Inc. 149.61 Thousand USD -946.025%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -581.35%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -1009.929%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -1856.25%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 79.987%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -324.063%
International Stem Cell Corporation 445 Thousand USD -251.685%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 80.798%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -242.451%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -34.798%
PureTech Health plc 18.25 Million USD 91.425%
Coeptis Therapeutics, Inc. 150 Thousand USD -943.333%
IXICO plc 275 Thousand USD -469.091%
IntelGenx Technologies Corp. 11.83 Million USD 86.781%
Gelesis Holdings, Inc. 26.3 Million USD 94.051%
CSL Limited 11.23 Billion USD 99.986%
Cellectis S.A. 36.21 Million USD 95.678%